tainiing gram-negative bacilli.
Most studies of immunity to infection have been concerned primarily with type-specific immune mechanisms. Little attention has been directed toward investigation of any potential protective effects mediated by antibodies to shared, cross-reactive antigens. Historically, cross-reactive antigens have proven important in the development of practical immunizing procedures as evidenced by Jenner's classical demonstration that cowpox protected against small-pox infection. More recently, prior infection with influenza A has been shown to protect mice against infection with influenza A2 (4, 13) . Similarly, studies by one of the authors have demonstrated that both active and passive immunization with a rough mutant, Re 595, of Salmonella minnesota afforded significant protection to mice against challenge with heterologous smooth gram-negative bacilli (9) .
The chemical similarity of the core region of the lipopolysaccharides of most gram-negative bacilli results in their sharing cross-reactive antigens (8) . One of the cross-reactive antigens shared by Enterobacteriaceae is the common enterobacterial antigen (CA) first described by . These studies demonstrated that, although most enterobacteria contain CA, only a few straiins of Escherichia coli (0:14, 0:56, 0:124, and 0:144) were capable of inducing an antibody response to CA. Although other investigators have elicited an antibody response to CA using semipurified ethanol-soluble fractions from other gram-negative bacilli (14) , highly purified CA prepared by both Kunin and in this laboratory have not proven to be immunogenic (5; M. Johns et al., J. Immunol., in press). Antibodies to CA have been demonstrated to opsonize heterologous gramnegative bacilli for phagocytosis (1) . In addition, equivocal prolongation of survival of Salmonellachallenged mice after immunzation with CA has suggested that antibody to CA might have protective activity in experimental animals (3) . These observations, plus previous demonstrations by the author of protective activity of antibody to other cross-reactive antigens (determinants of Re mutants) of gram-negative bacilli in both experimental animals and man (9, 11) , prompted the present studies to determine whether immunization with CA protected experimental animals against challenge with heterologous gramnegative bacilli.
MATERIALS AND METHODS
Immunizing agents. E. coli 0:14 was supplied through the courtesy of Calvin Kunin. An additional strain of E. coli 0:14 and E. coli 0:56, 0:124, and 0:144 were provided from the Center for Disease Control by John Winn. Immunization of mice or rabbits with these strains of E. coli induces an antibody response to CA as well as the 0-specific antigen of each strain.
IMMUNIZATION WITH CA
A strain of Pseudomonas aeruginosa isolated in the Bacteriology Laboratory, University Hospital, from a blood culture was used to provide a nonspecific endotoxin stimulus for control animals as previously described (9) . Immunization of mice and rabbits with this strain of P. aeruginosa, which does not contain CA, did not elicit an antibody response to CA or the Re determinant of S. minnesota.
Infecting agents. Two species of mouse virulent gram-negative bacilli were used as challenge agents. The Caroli strain of K. pneumoniae type II was obtained from Louis Chedid of the Pasteur Institute. The second challenge strain, a smooth, nontypable E. coli 107, had been isolated from a blood culture of a patient with bacteremia. The characteristics of the infections produced by these bacteria are described in an earlier publication (9) . Both of these challenge strains were shown to contain CA (see below).
Immunization of mice. Mice were immunized with E. coli 0:14, 0:56, 0:124, and 0:144 to induce antibodies to CA. Single-colony isolates of each strain were inoculated into 10 ml of brain heart infusion (BHI) broth. After overnight incubation at 37 C, this was spread onto BHI agar plates to prepare a lawn. These plates were incubated overnight and the bacterial growth was harvested in 10 ml of 0.9% saline. The bacteria were washed three times in 0.9% saline, resuspended in 10 ml of saline, and boiled for 2.5 h. This antigen preparation was diluted 1:10 with 0.9% saline before immunization (42 X 108 bacteria/ml).
Twenty-to 22-g male, CF1 mice were injected intraperitoneally with 0.2 ml of the E. coli 0:14, 0:56, 0:124, and 0:144 antigen suspensions for 3 consecutive days of each week for 2 weeks and then once weekly for 2 weeks. Five days later, lots of 10 mice were bled from the retro-orbital plexus, the blood was pooled, the serum was separated, and antibody titers were determined by indirect hemagglutination. If antibody titers to CA were less than 1:640, weekly injections of antigen were continued until titers of antibody to CA of 1:640 or greater were attained. After final injection of antigen, at least 1 week was allowed to elapse before challenge to minimize any nonspecific protective effect of endotoxin.
Immunization of rabbits. Antisera to CA was prepared by immunization of rabbits with E. coli 0:14, 0:56, 0:124, and 0:144 using methods similar to those described for the preparation of antigens for immunization of mice. The bacterial growth was harvested in 10 ml of 0.9% saline, washed three times in saline, resuspended in 10 ml of saline, and killed by the addition of 0.5% Formalin. This material was resuspended in saline to 80%o transmission at 550 nm in a Coleman spectrophotometer prior to rabbit immunization. Groups of three rabbits were immunized by intravenous injection of 0.5, 1.0, 2.0, 4.0, and 4.0 ml at 4-to 5-day intervals. Animals were bled for antibody determination 7 days after the last injection of antigen. If satisfactory titers of antibody had been attained, animals were anesthetized and exsanguinated. After separation of serum, Merthiolate was added to a concentration of 1:10,000 as a preservative, and the serum was stored at -70 C until used.
Hemagglutination reaction for CA. Titrations of antibody to CA were performed by modification of the indirect hemagglutination technique of Neter (12) using erythrocytes coated with extracts of a bacillus previously shown to contain large quantities of CA, Proteus rettgeri 6572 (11) . P. rettgeri 6572 was grown overnight at 37 C oni BHI agar and harvested in 10 ml of saline. The bacterial suspeusion was boiled for 2.5 h and centrifuged at 6,000 rpm at 4 C, and the supernatant was removed. One milliliter of 95% ethyl alcohol was added to the supernatant. A 1:10 dilution of this crude antigen preparation was incubated with an equal volume of a 2.5% suspeusion of human group O erythrocytes in phosphate-buffered saline (PBS) for 1 h at 37 C in a shaker water bath. The sensitized erythrocytes were washed three times in PBS and resuspended at a 0.5% concentration for immediate use in the hemagglutination test. Serum was serially diluted in PBS in test tubes (13 by 100 mm) at dilutions ranging from 1:10 to 1:163,840, and an equal volume of sensitized erythrocytes was added. Tubes were incubated for 1 h at 37 C, refrigerated overnight at 4 C, and read by pattern and for agglutination after shaking.
Hemmagglutination inhibition. Hemagglutination-inhibition studies were performed using the methods described for indirect hemagglutination except that 0.2 ml of boiled extracts of Enterobacter aerogenee, another CA containing strain (11), was added to one series of antiserum dilutions while 0.2 ml of PBS was added to a duplicate set as controls. Antiserum and the inhibiting antigen extract were incubated for 1 h at 37 C prior to addition of sensitized erythrocyes. Antibody titers to CA were considered to be those titers in serum from mice or rabbits immunized with E. coli 0:14 which agglutinated erythrocytes coated with extracts of P. rettgeri and which was completely blocked by extracts of E. aerogenes. Confirmation that hemagglutination inhibition with E. aerogenes accurately reflected inhibition of antibodies to CA was obtained by demonstration of identical results when highly purified CA (M. Johns, et al., J. Immunol., in press) was used for inhibition.
CA content of challenge strains. Content of CA of the two challenge strains, K. pneumoniae type II and E. coli 107, was determined by hemagglutination inhibition as described above. The maximal dilution of each organism capable of inhibiting agglutination of erythrocytes coated by P. rettgeri 6572 by 4 to 8 hemagglutinating units of E. coli 0:14 antiserum was considered to represent their CA content and was reported as hemaggluti- Mercaptoethanol treatment. Treatment with 2-mercaptoethanol was used to distinguish 19s from 7s antibody to CA. A 0.05-ml amount of 1 M 2-mercaptoethanol was added to serial dilutions of serum and incubated at 37 C for 1 h. Sensitized erythrocytes were then added and incubated for 1 h. Concomitant titrations of each serum specimen, untreated with 2-mercaptoethanol, were run for comparison.
Adsorption with Re determinants and CA. Adsorption of rabbit antiserum to CA was carried out using the Re 595 mutant of S. minnesota. Bacteria were grown overnight in meat extract broth, removed by centrifugation, washed three times in saline, and killed and dried with acetone. To prevent release of endotoxin and toxicity of the Readsorbed serum, dried bacteria were hydrolyzed in 1% acetic acid at 100 C for 2 h prior to adsorption of CA antiserum.
Preliminary investigation revealed that 1 mg of purified CA per ml would remove all the CA antibody from antiserum 166. Six milliliters of 166 antiserum was added to 6 mg of CA dissolved in 0.2 ml of PBS. The mixture was held at room temperature for 1 h and then at 4 C for 3 days with daily shaking to resuspend the precipitate. The Once titers of 1: 640 or greater to CA had been achieved, at least 1 week was allowed to elapse after the last injection of antigen before the immunized mnice and control animals were challenged with 100 LD10 units of K. pneumoniae (106) or E. coli 107 (109) to obviate any nonspecific protective effects of endotoxin. The results of these studies are illustrated in Table 1 . Since no significant differences in fatality rates were observed between controls injected with saline or P. aeruginosa, both groups of controls were combined for analysis. Survival rates in animals immunized with CA prior to challenge with K pneumoniae were 23%, whereas 30% of control animals survived. Slightly higher survival rates (49%) were observed in CA-immunized mice than in controls challenged with E. coli 107 (31%), but this difference was not statistically significant Passive immunization. The ability of passively transferred rabbit antiserum to CA to protect against challenge with. heterologous gramnegative bacilli was also evaluated. Antibody titers to CA in rabbits immunized with E. coli 0:56, 0:124, and 0:144 were considerably lower than those in rabbits immunized with E. coli 0:14, similar to the results observed in mice. Because of the low titers of CA in rabbits immunized with E. coli 0: 56, 0:124, and 0: 144, the protective activity of the antisera was not studied. Mice were injected intravenously with 0.3 ml of saline, normal rabbit serum, or serum from rabbits immunized with CA (E. coli 0:14) and challenged 60 minutes later by the injection of 10' K. pneumoniae or 10' E. coli 107 intravenously. The results observed with three different antisera (166, 324, 422) , and the titers of antibody to CA and other antigens of these antisera are shown in Table 3 . Titers of antibody to CA varied from 1:10,240 to 1:163,840 in the three sera studied. The demonstration that agglutination of erythrocytes coated with extracts of P. rettgeri 6572 was completely inhibited by extracts of an unrelated species, E. aerogenes, as well as purified CA, indicated that these were antibodies to CA. Antibody titers ranging from 1:160 to 1:5,120 to the challenge strains were also observed. However, the ability of extracts of E. aerogenes and purified CA to completely inhibit agglutination of erythrocytes sensitized with extracts of the challenge strains demonstrated that such antibody was directed against CA present in the two challenge strains rather than 0-specific antibody. Measurement of CA content in extracts of the two challenge strains revealed >1,000 hemagglutinationinhibiting units per ml of K. pneumoniae extracts and 320 units/ml of E. coli 107 extracts. One of the CA antisera, 166, also contained antibody Studies were carried out to measure persistence of passively injected rabbit antiserum to CA. Serum obtained from four mice, 1 h after passive transfer of 0.3 ml of 324 antiserum, revealed that all had titers of antibody to CA of 1:2,560. Titers of 1:1,280 and 1:320 were present 6 h and 24 h, respectively, after passive transfer of rabbit antiserum 324.
Survival rates in mice passively immunized by intravenous injection of 0.3 ml of 324 or 422 antiserum to CA and subsequently challenged with K. pneumoniae or E. coli were not significantly greater than among controls given saline or normal rabbit serum (Table 3 ). In contrast, survival rates in mice given antiserum 166 and challenged with both K. pneumoniae (81%) and E. coli (90%) were significantly greater (X2 = 70; P < 0.001) than in control animals (10-33%).
The demonstration that only one of the three with both K. pneumoniae and E. coli, this protective activity was obliterated by adsorption with Re. Thus, the protective activity of CA antiserum 166 appeared to reflect its content only of antibody to Re rather than antibody to CA.
Additional studies were carried out with antiserum 166 after adsorption with purified CA. These studies were limited by the availability of only a small amount of 166 serum remaining after previous studies. Adsorption with purified CA reduced antibody titers from 1:10,240 to less than 1:20 but failed to inhibit its protective activity. Survival rates, 5 of 10 (50%), were signiificantly greater (X2 = 4.03; P < 0.05) in mice injected with 0.3 ml of 166 antiserum adsorbed with CA prior to challenge. In contrast, only 3 of 20 (15%) mice injected with normal rabbit serum survived challenge with E. coli 107. Thus, the protective activity of CA antiserum 166 failed to reflect its content of antibody to CA and reflected, instead, the antibody activity to another crossreacting antigen, determinants of Re mutants, of gram-negative bacilli.
DISCUSSION
The failure to demonstrate any protective effect of active or passive immunization with CA against lethal infections with either K. pneumoniae or E. coli contrasts with earlier studies by the authors which have shown that immunization with another cross-reactive antigen, determinants of Re mutants, afforded significant protection against challenge with these same strains. The present investigations provided additional confirmation of the protective activity of antibody to Re. Only one of the three rabbit antisera to CA, 166, protected mice against challenge with K. pneumoniae and E. coli, but this antiserum was also the only one of the three which contained antibody against Re The failure to demonstrate protection against challenge with heterologous bacilli in mice actively and passively immunized with CA is consistent with observations in man. Studies of 206 episodes of gram-negative bacteremia demonstrated that bacteremia often developed despite the presence of high titers of antibody to CA and that high titers of CA did not ameliorate the severity of bacteremia. However, despite the lack of protective activity of antibody to CA in man, antibody to another shared, cross-reactive antigen (Re) did appear to be associated with lesser severity and enhanced survival in human gramnegative bacteremia analogous to observations in animals (10) . VoL. 7, 1973 
